Literature DB >> 7625735

Raloxifene is a tissue-selective agonist/antagonist that functions through the estrogen receptor.

R Fuchs-Young1, A L Glasebrook, L L Short, M W Draper, M K Rippy, H W Cole, D E Magee, J D Termine, H U Bryant.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7625735     DOI： 10.1111/j.1749-6632.1995.tb31392.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN： 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  18 in total

1.  A46, a benzothiophene-derived compound, suppresses Jak2-mediated pathologic cell growth.

Authors:  Anurima Majumder; Andrew T Magis; Sung O Park; Nicholas C Figueroa; Rebekah Baskin; Annet Kirabo; Robert W Allan; Zhizhuang Joe Zhao; Kirpal S Bisht; György M Keseru; Peter P Sayeski
Journal:  Exp Hematol       Date:  2011-10-20       Impact factor: 3.084

2.  Current and projected rates of hip fracture in Canada.

Authors:  E A Papadimitropoulos; P C Coyte; R G Josse; C E Greenwood
Journal:  CMAJ       Date:  1997-11-15       Impact factor: 8.262

3.  Raloxifene Ameliorates Liver Fibrosis of Nonalcoholic Steatohepatitis Induced by Choline-Deficient High-Fat Diet in Ovariectomized Mice.

Authors:  Fangqiong Luo; Masatoshi Ishigami; Koichi Achiwa; Yoji Ishizu; Teiji Kuzuya; Takashi Honda; Kazuhiko Hayashi; Tetsuya Ishikawa; Yoshiaki Katano; Hidemi Goto
Journal:  Dig Dis Sci       Date:  2015-04-14       Impact factor: 3.199

4.  Endometriosis impairs bone marrow-derived stem cell recruitment to the uterus whereas bazedoxifene treatment leads to endometriosis regression and improved uterine stem cell engraftment.

Authors:  Sharif Sakr; Hanyia Naqvi; Barry Komm; Hugh S Taylor
Journal:  Endocrinology       Date:  2014-01-31       Impact factor: 4.736

5.  Celecoxib affects estrogen sulfonation catalyzed by several human hepatic sulfotransferases, but does not stimulate 17-sulfonation in rat liver.

Authors:  Sriram Ambadapadi; Peter L Wang; Sergiu P Palii; Margaret O James
Journal:  J Steroid Biochem Mol Biol       Date:  2017-05-25       Impact factor: 4.292

6.  Selective estrogen receptor modulation in pancreatic β-cells and the prevention of type 2 diabetes.

Authors:  Joseph Tiano; Franck Mauvais-Jarvis
Journal:  Islets       Date:  2012-03-01       Impact factor: 2.694

7.  Treatment with bazedoxifene, a selective estrogen receptor modulator, causes regression of endometriosis in a mouse model.

Authors:  Jaime Kulak; Catha Fischer; Barry Komm; Hugh S Taylor
Journal:  Endocrinology       Date:  2011-05-17       Impact factor: 4.736

8.  Long-term safety and efficacy of raloxifene in the prevention and treatment of postmenopausal osteoporosis: an update.

Authors:  Enrico M Messalli; Cono Scaffa
Journal:  Int J Womens Health       Date:  2010-08-09

9.  Return of chronic pelvic pain from endometriosis after raloxifene treatment: a randomized controlled trial.

Authors:  Pamela Stratton; Ninet Sinaii; James Segars; Deloris Koziol; Robert Wesley; Carolyn Zimmer; Craig Winkel; Lynnette K Nieman
Journal:  Obstet Gynecol       Date:  2008-01       Impact factor: 7.661

10.  Treatment with bazedoxifene and conjugated estrogens results in regression of endometriosis in a murine model.

Authors:  Hanyia Naqvi; Sharif Sakr; Thomas Presti; Graciela Krikun; Barry Komm; Hugh S Taylor
Journal:  Biol Reprod       Date:  2014-04-16       Impact factor: 4.285
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.